Literature DB >> 22958893

miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma.

Mingxin Zhang1, Suna Zhou, Lingmin Zhang, Jia Zhang, Hui Cai, Jinxiang Zhu, Chen Huang, Jiansheng Wang.   

Abstract

MicroRNAs (miRNAs) represent a class of small non-coding RNAs that regulate gene expression at the post-transcriptional levels. Recent studies show that miRNAs may function as oncogenes or tumor suppressor genes. In this study, we demonstrated that miR-518b was down-regulated in esophageal squamous cell carcinoma (ESCC) tissues and correlated with metastasis and survival. miR-518b suppressed the proliferation by inducing apoptosis and repressed the invasion in ESCC cells, but had no effect on the cell cycle. Furthermore, Rap1b was revealed to be directly regulated by miR-518b. These findings indicate that miR-518b may function as a tumor suppressor by targeting Rap1b in the development of ESCC and has important clinical and prognostic value.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22958893     DOI: 10.1016/j.febslet.2012.08.007

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

Review 2.  Ras and Rap1: A tale of two GTPases.

Authors:  Seema Shah; Ethan J Brock; Kyungmin Ji; Raymond R Mattingly
Journal:  Semin Cancer Biol       Date:  2018-04-03       Impact factor: 15.707

3.  Fentanyl inhibits proliferation and invasion via enhancing miR-302b expression in esophageal squamous cell carcinoma.

Authors:  Ning Wang; Zhenni Zhang; Jianrui Lv
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

Review 4.  MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets.

Authors:  J Huang; S-Y Zhang; Y-M Gao; Y-F Liu; Y-B Liu; Z-G Zhao; K Yang
Journal:  Cell Prolif       Date:  2014-06-06       Impact factor: 6.831

5.  miR-181 subunits enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeleton remodeling in glioblastoma cells.

Authors:  Xiaoling She; Zhibin Yu; Yulong Cui; Qianqian Lei; Zeyou Wang; Gang Xu; Zhaohui Luo; Guiyuan Li; Minghua Wu
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064

6.  Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.

Authors:  F Garibaldi; E Falcone; D Trisciuoglio; T Colombo; K Lisek; D Walerych; G Del Sal; P Paci; G Bossi; G Piaggio; A Gurtner
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

7.  Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B.

Authors:  Kai-Ti Lin; Yu-Ming Yeh; Chi-Mu Chuang; Scarlett Y Yang; Jer-Wei Chang; Shu-Pin Sun; Yi-Shiang Wang; Kuan-Chong Chao; Lu-Hai Wang
Journal:  Nat Commun       Date:  2015-01-08       Impact factor: 14.919

8.  MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.

Authors:  Richard Ottman; Camha Nguyen; Robert Lorch; Ratna Chakrabarti
Journal:  Mol Cancer       Date:  2014-01-03       Impact factor: 27.401

9.  miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.

Authors:  Sen Jiang; Chao Zhao; Xiaodi Yang; Xiangyang Li; Qing Pan; Haijin Huang; Xuyang Wen; Husheng Shan; Qianwen Li; Yunxiang Du; Yaping Zhao
Journal:  Int J Mol Med       Date:  2016-05-31       Impact factor: 4.101

Review 10.  Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity.

Authors:  Aymone Gurtner; Emmanuela Falcone; Francesca Garibaldi; Giulia Piaggio
Journal:  J Exp Clin Cancer Res       Date:  2016-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.